Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions.
Schmid I, Bonnington L, Gerl M, Bomans K, Thaller AL, Wagner K, Schlothauer T, Falkenstein R, Zimmermann B, Kopitz J, Hasmann M, Bauss F, Haberger M, Reusch D, Bulau P.
Schmid I, et al. Among authors: falkenstein r.
Commun Biol. 2018 Apr 5;1:28. doi: 10.1038/s42003-018-0032-8. eCollection 2018.
Commun Biol. 2018.
PMID: 30271914
Free PMC article.